Dr. Piotr Wysocki
Claim this profileSP ZOZ Szpital Uniwersytecki w Krakowie, Oddzial Onkologii Klinicznej
Area of expertise
Breast Cancer
Piotr Wysocki has run 3 trials for Breast Cancer. Some of their research focus areas include:
Prostate Cancer
Piotr Wysocki has run 2 trials for Prostate Cancer. Some of their research focus areas include:
Clinical Trials Piotr Wysocki is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting
2 awards
Phase 3
12 criteria
Futibatinib
for Bile Duct Cancer
This is an open-label, multinational, randomized Phase 2 study confirming the clinical benefit of 20 mg futibatinib and evaluating the safety and efficacy of 16 mg futibatinib in previously treated CCA harboring FGFR2 gene fusions and other rearrangements.
Recruiting
1 award
Phase 2
More about Piotr Wysocki
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Piotr Wysocki has experience with
- Abemaciclib
- Fulvestrant
- Lasofoxifene
- MGA012
- MGC018
- Abiraterone Acetate
Breakdown of trials Piotr Wysocki has run
Breast Cancer
Prostate Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Piotr Wysocki specialize in?
Piotr Wysocki focuses on Breast Cancer and Prostate Cancer. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are Stage IV.
Is Piotr Wysocki currently recruiting for clinical trials?
Yes, Piotr Wysocki is currently recruiting for 2 clinical trials in the USA. If you're interested in participating, you should apply.
Are there any treatments that Piotr Wysocki has studied deeply?
Yes, Piotr Wysocki has studied treatments such as Abemaciclib, Fulvestrant, Lasofoxifene.
What is the best way to schedule an appointment with Piotr Wysocki?
Apply for one of the trials that Piotr Wysocki is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.